Alejandro F Siller1, Heather Lugar2, Jerrel Rutlin2, Jonathan M Koller2, Katherine Semenkovich3, Neil H White3,4,5, Ana Maria Arbelaez3,5, Joshua Shimony6, Tamara Hershey2,5,7. 1. Washington University School of Medicine, St. Louis, Missouri. 2. Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri. 3. Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri. 4. Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 5. St. Louis Children's Hospital, St. Louis, Missouri. 6. Department of Radiology, Washington University School of Medicine, St. Louis, Missouri. 7. Department of Neurology, Washington University School of Medicine, St. Louis, Missouri.
Abstract
OBJECTIVE: Differences in cognition and brain structure have been found in youth with type 1 diabetes compared with controls, even after relatively short disease duration. To determine whether severity of clinical presentation contributes to these differences, we obtained structural magnetic resonance imaging (MRI) scans in youth ages 7-17 who were either newly diagnosed with type 1 diabetes (<3.5 months from diagnosis, n = 46) or a sibling without diabetes (n = 28). RESEARCH DESIGN AND METHODS: Severity of presentation was measured by the presence of diabetic ketoacidosis (DKA) and degree of hyperglycemia exposure [hemoglobin A1c (HbA1c)] at diagnosis. MRI were obtained using T1-weighted, T2-weighted, and diffusion-weighted sequences. RESULTS: Within the group with type 1 diabetes, 12 subjects presented in DKA and 34 did not. After controlling for age, sex, and multiple comparisons, the type 1 diabetes group had lower volume in the left temporal-parietal-occipital cortex compared with controls. Within the type 1 diabetes group, DKA at presentation was associated with lower radial, axial, and mean diffusivity (MD) throughout major white matter tracts and higher HbA1c was associated with lower hippocampal, thalamic, and cerebellar white matter volumes, lower right posterior parietal cortical thickness, and greater right occipital cortical thickness. CONCLUSION: These data suggest that severity of clinical presentation is an important factor in predicting brain structural differences in youth with type 1 diabetes approximately 3 months after diagnosis.
OBJECTIVE: Differences in cognition and brain structure have been found in youth with type 1 diabetes compared with controls, even after relatively short disease duration. To determine whether severity of clinical presentation contributes to these differences, we obtained structural magnetic resonance imaging (MRI) scans in youth ages 7-17 who were either newly diagnosed with type 1 diabetes (<3.5 months from diagnosis, n = 46) or a sibling without diabetes (n = 28). RESEARCH DESIGN AND METHODS: Severity of presentation was measured by the presence of diabetic ketoacidosis (DKA) and degree of hyperglycemia exposure [hemoglobin A1c (HbA1c)] at diagnosis. MRI were obtained using T1-weighted, T2-weighted, and diffusion-weighted sequences. RESULTS: Within the group with type 1 diabetes, 12 subjects presented in DKA and 34 did not. After controlling for age, sex, and multiple comparisons, the type 1 diabetes group had lower volume in the left temporal-parietal-occipital cortex compared with controls. Within the type 1 diabetes group, DKA at presentation was associated with lower radial, axial, and mean diffusivity (MD) throughout major white matter tracts and higher HbA1c was associated with lower hippocampal, thalamic, and cerebellar white matter volumes, lower right posterior parietal cortical thickness, and greater right occipital cortical thickness. CONCLUSION: These data suggest that severity of clinical presentation is an important factor in predicting brain structural differences in youth with type 1 diabetes approximately 3 months after diagnosis.
Authors: Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Neuron Date: 2002-01-31 Impact factor: 17.173
Authors: A M Wessels; S Simsek; P L Remijnse; D J Veltman; G J Biessels; F Barkhof; P Scheltens; F J Snoek; R J Heine; S A R B Rombouts Journal: Diabetologia Date: 2006-05-16 Impact factor: 10.122
Authors: Gail Musen; In Kyoon Lyoo; Caitlin R Sparks; Katie Weinger; Jaeuk Hwang; Christopher M Ryan; David C Jimerson; John Hennen; Perry F Renshaw; Alan M Jacobson Journal: Diabetes Date: 2006-02 Impact factor: 9.461
Authors: Dana C Perantie; Audrey Lim; Jenny Wu; Patrick Weaver; Stacie L Warren; Michelle Sadler; Neil H White; Tamara Hershey Journal: Pediatr Diabetes Date: 2008-01-12 Impact factor: 4.866
Authors: Nicole S Glaser; Sandra L Wootton-Gorges; James P Marcin; Michael H Buonocore; Joseph Dicarlo; E Kirk Neely; Patrick Barnes; Jenny Bottomly; Nathan Kuppermann Journal: J Pediatr Date: 2004-08 Impact factor: 4.406
Authors: Larry A Fox; Tamara Hershey; Nelly Mauras; Ana Maria Arbeláez; William V Tamborlane; Bruce Buckingham; Eva Tsalikian; Kim Englert; Mira Raman; Booil Jo; Hanyang Shen; Allan Reiss; Paul Mazaika Journal: Diabetologia Date: 2018-04-13 Impact factor: 10.122
Authors: Sujung Yoon; Jungyoon Kim; Gail Musen; Perry F Renshaw; Jaeuk Hwang; Nicolas R Bolo; Jieun E Kim; Donald C Simonson; Katie Weinger; Christopher M Ryan; In Kyoon Lyoo; Alan M Jacobson Journal: Pediatr Diabetes Date: 2017-09-20 Impact factor: 4.866
Authors: Simona Ghetti; Nathan Kuppermann; Arleta Rewers; Sage R Myers; Jeff E Schunk; Michael J Stoner; Aris Garro; Kimberly S Quayle; Kathleen M Brown; Jennifer L Trainor; Leah Tzimenatos; Andrew D DePiero; Julie K McManemy; Lise E Nigrovic; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; Nicole S Glaser Journal: Diabetes Care Date: 2020-09-22 Impact factor: 19.112
Authors: Nathan Kuppermann; Simona Ghetti; Jeff E Schunk; Michael J Stoner; Arleta Rewers; Julie K McManemy; Sage R Myers; Lise E Nigrovic; Aris Garro; Kathleen M Brown; Kimberly S Quayle; Jennifer L Trainor; Leah Tzimenatos; Jonathan E Bennett; Andrew D DePiero; Maria Y Kwok; Clinton S Perry; Cody S Olsen; T Charles Casper; J Michael Dean; Nicole S Glaser Journal: N Engl J Med Date: 2018-06-14 Impact factor: 91.245
Authors: Tandy Aye; Paul K Mazaika; Nelly Mauras; Matthew J Marzelli; Hanyang Shen; Tamara Hershey; Allison Cato; Stuart A Weinzimer; Neil H White; Eva Tsalikian; Booil Jo; Allan L Reiss Journal: Diabetes Care Date: 2018-12-20 Impact factor: 19.112
Authors: Leonardo Calil Vicente Franco de Souza; Gabriela de Carvalho Kraemer; Adriana Koliski; José Eduardo Carreiro; Mônica Nunes Lima Cat; Luiz De Lacerda; Suzana Nesi França Journal: Rev Paul Pediatr Date: 2019-11-25
Authors: Lara C Foland-Ross; Bruce Buckingam; Nelly Mauras; Ana Maria Arbelaez; William V Tamborlane; Eva Tsalikian; Allison Cato; Gabby Tong; Kimberly Englert; Paul K Mazaika; Allan L Reiss Journal: PLoS Med Date: 2019-12-09 Impact factor: 11.069
Authors: Rachel A Whitmer; Paola Gilsanz; Charles P Quesenberry; Andrew J Karter; Mary E Lacy Journal: Neurology Date: 2021-06-02 Impact factor: 11.800